The Serotonin-1A Receptor in Anxiety Disorders

The serotonin system plays an important role in the neural processing of anxiety. The involvement of the main inhibitory serotonergic receptor, the serotonin-1A (5-HT1A) subtype, in dysfunctional forms of anxiety has been supported by findings from a wide range of preclinical research and clinical trials, including treatment studies, genetic research, and neuroimaging data. The following article summarizes preclinical results with a focus on 5-HT1A receptor knockout and transgenic mice as genetic models of anxiety. Behavioral, autonomic, and endocrinological changes in these mice are reported. This article also presents genetic polymorphisms in humans associated with increased anxiety scores and pharmacological data focused on 5-HT1A receptor agonists and antagonists. Furthermore, molecular neuroimaging results are presented. Recent positron emission tomography (PET) studies have reported reduced 5-HT1A receptor binding in patients with panic disorder and social anxiety disorder, but not in posttraumatic stress disorder. In healthy subjects, increased anxiety scores might be associated with lower 5-HT1A receptor binding. This overview of preclinical and clinical data provides strong evidence for the key role of the 5-HT1A receptor in the serotonergic dysregulation of anxiety disorders.

[1]  K. Lesch,et al.  Knockout Corner: 5-HT(1A) receptor inactivation: anxiety or depression as a murine experience. , 1999, The international journal of neuropsychopharmacology.

[2]  S Kasper,et al.  Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders , 2009, Molecular Psychiatry.

[3]  H. Akil,et al.  Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  C. Pavlides,et al.  Genetic Inactivation of the Serotonin1A Receptor in Mice Results in Downregulation of Major GABAA Receptor α Subunits, Reduction of GABAA Receptor Binding, and Benzodiazepine-Resistant Anxiety , 2000, The Journal of Neuroscience.

[5]  M. Ansorge,et al.  Inhibition of Serotonin But Not Norepinephrine Transport during Development Produces Delayed, Persistent Perturbations of Emotional Behaviors in Mice , 2008, The Journal of Neuroscience.

[6]  René Hen,et al.  Increased Fear Response to Contextual Cues in Mice Lacking the 5-HT1A Receptor , 2006, Neuropsychopharmacology.

[7]  M. Meaney,et al.  Maternal care and the development of stress responses , 1999, Current Opinion in Neurobiology.

[8]  R. Balon,et al.  Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone. , 1989, Psychopathology.

[9]  D. Kupfer,et al.  Serotonin-1A receptor imaging in recurrent depression: replication and literature review. , 2007, Nuclear medicine and biology.

[10]  L H Parsons,et al.  Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Judy L. Cameron,et al.  Sensitivity to stress-induced reproductive dysfunction linked to activity of the serotonin system. , 2005, Fertility and sterility.

[12]  V. Pérez,et al.  Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. , 1994, Archives of general psychiatry.

[13]  F. Champagne,et al.  Maternal Care, Gene Expression, and the Development of Individual Differences in Stress Reactivity , 1999, Annals of the New York Academy of Sciences.

[14]  René Hen,et al.  Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult , 2002, Nature.

[15]  René Hen,et al.  Altered fear circuits in 5-HT1A receptor KO mice , 2000, Biological Psychiatry.

[16]  K. Lesch,et al.  Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics. , 2004, The international journal of neuropsychopharmacology.

[17]  A. Broocks,et al.  Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects , 2001, Psychopharmacology.

[18]  Gabriele Flügge,et al.  5-HT1A receptor expression in pyramidal neurons of cortical and limbic brain regions , 2005, Cell and Tissue Research.

[19]  Jordi Serrats,et al.  Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. , 2004, Cerebral cortex.

[20]  B Olivier,et al.  The 5-HT1A receptor and its ligands: structure and function. , 1999, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[21]  R. Veh,et al.  Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors. , 2004, Brain research. Molecular brain research.

[22]  M Toth,et al.  Increased anxiety of mice lacking the serotonin1A receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Mann,et al.  Brain Serotonin1A Receptor Binding in Major Depression Is Related to Psychic and Somatic Anxiety , 2005, Biological Psychiatry.

[24]  P. Celada,et al.  Involvement of 5-HT1A Receptors in Prefrontal Cortex in the Modulation of Dopaminergic Activity: Role in Atypical Antipsychotic Action , 2005, The Journal of Neuroscience.

[25]  P. Celada,et al.  Pindolol augmentation of antidepressant response. , 2006, Current drug targets.

[26]  Roger N. Gunn,et al.  A Database of [11C]WAY-100635 Binding to 5-HT1A Receptors in Normal Male Volunteers: Normative Data and Relationship to Methodological, Demographic, Physiological, and Behavioral Variables , 2002, NeuroImage.

[27]  N. Cutler,et al.  A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[28]  D. Nutt,et al.  Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. , 2008, The British journal of psychiatry : the journal of mental science.

[29]  Laurent Descarries,et al.  Decreased [18F]MPPF Binding Potential in the Dorsal Raphe Nucleus After a Single Oral Dose of Fluoxetine: A Positron-Emission Tomography Study in Healthy Volunteers , 2008, Biological Psychiatry.

[30]  M. Bourin,et al.  Blockade of 5-HT1A Receptors by (±)-Pindolol Potentiates Cortical 5-HT Outflow, but not Antidepressant-Like Activity of Paroxetine: Microdialysis and Behavioral Approaches in 5-HT1A Receptor Knockout Mice , 2006, Neuropsychopharmacology.

[31]  P A Sargent,et al.  Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635 , 2004, Molecular Psychiatry.

[32]  H. Wikström,et al.  Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635 , 1997, Brain Research.

[33]  D. Sheehan,et al.  Is Buspirone Effective for Panic Disorder? , 1990, Journal of clinical psychopharmacology.

[34]  S. Watson,et al.  Regulation of Serotonin1A, Glucocorticoid, and Mineralocorticoid Receptor in Rat and Human Hippocampus: Implications for the Neurobiology of Depression , 1998, Biological Psychiatry.

[35]  E. Azmitia,et al.  Cellular Localization of the 5-HT1A Receptor in Primate Brain Neurons and Glial Cells , 1996, Neuropsychopharmacology.

[36]  Cloninger Cr.  A systematic method for clinical description and classification of personality variants: A proposal. , 1987 .

[37]  P A Sargent,et al.  Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.

[38]  Gustavo Turecki,et al.  Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide , 2003, The Journal of Neuroscience.

[39]  H. L. Goldberg,et al.  The comparative efficacy of buspirone and diazepam in the treatment of anxiety. , 1979, The American journal of psychiatry.

[40]  Richard De La Garza,et al.  Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. , 2003, Stress.

[41]  B. Olivier,et al.  The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effects. , 1995, European journal of pharmacology.

[42]  C. Halldin,et al.  Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain , 2004, Human brain mapping.

[43]  W. Drevets,et al.  No change in serotonin type 1A receptor binding in patients with posttraumatic stress disorder. , 2005, The American journal of psychiatry.

[44]  Hans-Jürgen Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision , 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[45]  Tommy Pattij,et al.  Stress-induced hyperthermia and anxiety: pharmacological validation. , 2003, European journal of pharmacology.

[46]  K. Lesch,et al.  Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans , 1989, Biological Psychiatry.

[47]  E. Rüther,et al.  5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo , 2003, European Neuropsychopharmacology.

[48]  D. Overstreet,et al.  Brain 5-HT1A receptor autoradiography and hypothermic responses in rats bred for differences in 8-OH-DPAT sensitivity , 1998, Brain Research.

[49]  I. Lucki,et al.  Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. , 2001, The Journal of pharmacology and experimental therapeutics.

[50]  B. McEwen.  Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. , 2008, European journal of pharmacology.

[51]  O. Meijer,et al.  Regulation of the Rat Serotonin-1A Receptor Gene by Corticosteroids* , 2000, The Journal of Biological Chemistry.

[52]  P. Celada,et al.  Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. , 2004, Cerebral cortex.

[53]  K. Lesch.  Molecular foundation of anxiety disorders , 2001, Journal of Neural Transmission.

[54]  M. Toth,et al.  5-HT1A receptor knockout mouse as a genetic model of anxiety. , 2003, European journal of pharmacology.

[55]  P. Celada,et al.  Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. , 2004, Cerebral cortex.

[56]  Carolyn C. Meltzer,et al.  Exaggerated 5-HT1A but Normal 5-HT2A Receptor Activity in Individuals Ill with Anorexia Nervosa , 2007, Biological Psychiatry.

[57]  C. McDougle,et al.  Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. , 1993, The American journal of psychiatry.

[58]  Rupert Lanzenberger,et al.  Simple and fully automated preparation of [carbonyl-11C]WAY-100635 , 2007 .

[59]  Kenneth S Kendler,et al.  Genetic and environmental sources of covariation between generalized anxiety disorder and neuroticism. , 2004, The American journal of psychiatry.

[60]  P. Dannon,et al.  Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial , 2000, European Neuropsychopharmacology.

[61]  R. Lydiard,et al.  Brain circuits in panic disorder , 1998, Biological Psychiatry.

[62]  Rupert Lanzenberger,et al.  Aggression is related to frontal serotonin‐1A receptor distribution as revealed by PET in healthy subjects , 2009, Human brain mapping.

[63]  L. Siever,et al.  Effects of ipsapirone in healthy subjects: a dose-response study , 1994, Psychopharmacology.

[64]  R Hen,et al.  Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[65]  L. Parsons,et al.  5‐HT1A receptor mutant mice exhibit enhanced tonic, stress‐induced and fluoxetine‐induced serotonergic neurotransmission , 2001, Journal of neurochemistry.

[66]  D. Kupfer,et al.  Measurement of 5‐HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY‐100635 , 2007, Synapse.

[67]  I. Cliffe,et al.  A retrospect on the discovery of WAY-100635 and the prospect for improved 5-HT(1A) receptor PET radioligands. , 2000, Nuclear medicine and biology.

[68]  Victoria Arango,et al.  Serotonin 1A Receptors, Serotonin Transporter Binding and Serotonin Transporter mRNA Expression in the Brainstem of Depressed Suicide Victims , 2001, Neuropsychopharmacology.

[69]  G. Dawson,et al.  On the elevated plus-maze the anxiolytic-like effects of the 5-HT1A agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT1A partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635 , 1997, Psychopharmacology.

[70]  P A Sargent,et al.  Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. , 1996, European journal of pharmacology.

[71]  Rene Hen,et al.  The developmental origins of anxiety , 2004, Nature Reviews Neuroscience.

[72]  R. Hen,et al.  Altered Emotional States in Knockout Mice Lacking 5-HT1A or 5-HT1B Receptors , 1999, Neuropsychopharmacology.

[73]  K. Kendler,et al.  Low extraversion and high neuroticism as indices of genetic and environmental risk for social phobia, agoraphobia, and animal phobia. , 2007, The American journal of psychiatry.

[74]  M Toth,et al.  Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[75]  J. Gorman,et al.  Serotonin related functions in panic-anxiety: a critical overview. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[76]  K. Lesch.  Mouse anxiety: the power of knockout , 2001, The Pharmacogenomics Journal.

[77]  K. Lesch.  5-HT1A receptor responsivity in anxiety disorders and depression , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[78]  C. Halldin,et al.  Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[79]  K. Lesch,et al.  5-HT1A Receptor Function in Normal Subjects on Clinical Doses of Fluoxetine: Blunted Temperature and Hormone Responses to Ipsapirone Challenge , 1999, Neuropsychopharmacology.

[80]  R. Hen,et al.  Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice , 2004, Science.

[81]  Wolfgang Wadsak,et al.  Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder , 2007, Biological Psychiatry.

[82]  J. Vry,et al.  Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? , 1995, The Journal of pharmacology and experimental therapeutics.

[83]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[84]  P. Blier,et al.  Is there a role for 5-HT1A agonists in the treatment of depression? , 2003, Biological Psychiatry.

[85]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[86]  M. Toth,et al.  The 5-HT(1A) receptor knockout mouse and anxiety. , 2001, Behavioural pharmacology.

[87]  D. Nutt,et al.  Serotonin and panic , 1998, British Journal of Psychiatry.

[88]  Peter Herscovitch,et al.  Reduced Serotonin Type 1A Receptor Binding in Panic Disorder , 2004, The Journal of Neuroscience.

[89]  Lisa Weissfeld,et al.  Altered 5-HT2A Receptor Binding after Recovery from Bulimia-Type Anorexia Nervosa: Relationships to Harm Avoidance and Drive for Thinness , 2004, Neuropsychopharmacology.

[90]  T. Hijzen,et al.  Autonomic Changes Associated with Enhanced Anxiety in 5-HT1A Receptor Knockout Mice , 2002, Neuropsychopharmacology.

[91]  J Tauscher,et al.  Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety: a [(11)C]WAY-100635 PET investigation in healthy volunteers. , 2001, The American journal of psychiatry.

[92]  J. Calabrese,et al.  Buspirone augmentation of fluoxetine in obsessive-compulsive disorder. , 1990 .